← Back to Search

Digital Intervention for Binge Eating Disorder in Black Women

N/A
Waitlist Available
Led By Rachel Goode, PhD,MPH
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Over 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial found Black women are more likely to binge eat & struggle to get effective treatment. To reduce weight-related concerns, culturally-relevant treatments for binge eating must be available to Black women.

Who is the study for?
This trial is for Black women over 18 with obesity (BMI ≥ 30) who binge eat at least once a week and live or work within 30 miles of Kannapolis, NC. They must use a smartphone and complete a questionnaire. It's not for those in other weight programs, using drugs/alcohol heavily, pregnant, treating substance abuse/eating disorders, or with anorexia history.Check my eligibility
What is being tested?
'Centering Appetite' is being tested as a culturally-relevant digital treatment to help Black women manage obesity and binge eating. The study aims to address the high rates of obesity by focusing on reducing binge eating behaviors through accessible technology.See study design
What are the potential side effects?
Since 'Centering Appetite' is a behavioral intervention rather than medication, side effects may include emotional discomfort or stress due to changes in eating habits but are generally considered low-risk compared to drug treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attendance: Percentage of Intervention Sessions Attended
Feasibility (Recruitment): Total Number of Eligible Adults Enrolled in the Study
Retention: Percentage of Participants Retained in the Study
Secondary outcome measures
Change from Baseline to Month 3 in weight regain
Change from Baseline to Month 6 in weight regain
Change in number of Binge Eating Episodes from Baseline to Month 3
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Centering Appetite Intervention, Then Attention- Control GroupExperimental Treatment1 Intervention
Participants randomized to the attention-control group will participate remotely via a smartphone app and online lessons. The intervention will build participants' self-efficacy to reduce binge eating and to assist them in preventing weight gain.
Group II: Attention- Control Group, Then Centering Appetite InterventionActive Control1 Intervention
Participants randomized to the centering appetite intervention group will receive weekly psychoeducation emails about general wellness topics, discussion of binge eating, diet, and physical activity.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,498 Previous Clinical Trials
4,176,152 Total Patients Enrolled
64 Trials studying Obesity
57,994 Patients Enrolled for Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,338 Previous Clinical Trials
4,314,139 Total Patients Enrolled
440 Trials studying Obesity
588,055 Patients Enrolled for Obesity
Rachel Goode, PhD,MPHPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Media Library

Centering Appetite Clinical Trial Eligibility Overview. Trial Name: NCT05693896 — N/A
Obesity Research Study Groups: Centering Appetite Intervention, Then Attention- Control Group, Attention- Control Group, Then Centering Appetite Intervention
Centering Appetite 2023 Treatment Timeline for Medical Study. Trial Name: NCT05693896 — N/A
Obesity Clinical Trial 2023: Centering Appetite Highlights & Side Effects. Trial Name: NCT05693896 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant age range for this research study inclusive of seniors?

"This medical study has age requirements, only accepting individuals aged 18-75."

Answered by AI

Are there any openings left in this research endeavor?

"According to the clinicaltrials.gov website, this medical study is no longer recruiting patients as it was last updated on January 11th 2023. However, there are presently 1061 other trials actively enrolling participants."

Answered by AI

What outcome is this research attempting to uncover?

"This 6-month trial will primarily assess the attendance rate of participants. Secondary outcomes include change from baseline to Month 6 in weight regain, as well as changes in number of binge eating episodes over 3 and 6 months; these progressions can be monitored via a digital health platform."

Answered by AI

To whom does this clinical trial offer eligibility?

"This controlled study is seeking 60 individuals with binge eating disorder between 18-75 years of age. To be eligible, participants should have a BMI ≥ 30 kg/m^2; the ability to use Bluetooth on their phone; regular reports of weekly binging episodes; and reside or work within thirty miles of Kannapolis, NC. Additionally, they must complete an initial screening questionnaire."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I need to lose weight really really badly.
PatientReceived 1 prior treatment
~40 spots leftby Dec 2025